Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

354 recalls, newest first

Class II · Moderate risk

Liceout

CGMP violations.

Ongoing cGMP deviation Neogen Corporation D-0073-2025
Class III · Low risk

Ciclopirox Gel 0.77%

Defective Container: Firm received complaints of broken tube at the seal.

Ongoing Packaging defect Glenmark Pharmaceuticals Inc., USA NDC 68462-0455-35 D-0002-2025
Class III · Low risk

Kids' Cough and Chest Congestion

Crystallization: Lack of uniformity - a change in texture, chunky, grainy, and small crystal substances inside the bottles.

Ongoing Failed specification Denison Pharmaceuticals, LLC D-0034-2025
Class III · Low risk

Adult Cough and Chest Congestion

Crystallization: Lack of uniformity - a change in texture, chunky, grainy, and small crystal substances inside the bottles.

Ongoing Failed specification Denison Pharmaceuticals, LLC D-0033-2025
Class II · Moderate risk

Pluvicto

CGMP deviations

Ongoing cGMP deviation Advanced Accelerator Applications USA, Inc. NDC 69488-0010-61 D-0007-2025
Class II · Moderate risk

Refresh P.M.

Lack of Assurance of Sterility: The impacted lots may contain a breach in the tube seal.

Ongoing Sterility / contamination AbbVie Inc. D-0664-2024
Class II · Moderate risk

First Aid Antiseptic Ointment

Incorrect/Undeclared Excipients: The inactive ingredients labeled on the product boxes and tubes are listed as "mineral oil , petrolatum ". The inactive ingredients in the actual product are polyethylene glycol 400 , polyethylene glycol 4000.

Ongoing Chemical / undeclared Zhejiang Jingwei Pharmaceutical Co., Ltd. D-0013-2025

Recalls by year